FDA Inspection 1196973 — Richard Drachtman, M.D.
The FDA completed an inspection of Richard Drachtman, M.D. on Dec 22, 2022 in New Brunswick, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 22, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- New Brunswick, NJ (United States)
Additional details
Clinical Investigator (CI)